These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23347894)

  • 1. Alginate-coated chitosan nanogel capacity to modulate the effect of TLR ligands on blood dendritic cells.
    Démoulins T; Bassi I; Thomann-Harwood L; Jandus C; Kaeuper P; Simon HU; von Gunten S; McCullough KC
    Nanomedicine; 2013 Aug; 9(6):806-17. PubMed ID: 23347894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alginate-coated chitosan nanogels differentially modulate class-A and class-B CpG-ODN targeting of dendritic cells and intracellular delivery.
    Démoulins T; Milona P; McCullough KC
    Nanomedicine; 2014 Nov; 10(8):1739-49. PubMed ID: 24941461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanogel vaccines targeting dendritic cells: contributions of the surface decoration and vaccine cargo on cell targeting and activation.
    Thomann-Harwood LJ; Kaeuper P; Rossi N; Milona P; Herrmann B; McCullough KC
    J Control Release; 2013 Mar; 166(2):95-105. PubMed ID: 23220107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioreducible alginate-poly(ethylenimine) nanogels as an antigen-delivery system robustly enhance vaccine-elicited humoral and cellular immune responses.
    Li P; Luo Z; Liu P; Gao N; Zhang Y; Pan H; Liu L; Wang C; Cai L; Ma Y
    J Control Release; 2013 Jun; 168(3):271-9. PubMed ID: 23562637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
    Loré K; Betts MR; Brenchley JM; Kuruppu J; Khojasteh S; Perfetto S; Roederer M; Seder RA; Koup RA
    J Immunol; 2003 Oct; 171(8):4320-8. PubMed ID: 14530357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.
    Krug A; Towarowski A; Britsch S; Rothenfusser S; Hornung V; Bals R; Giese T; Engelmann H; Endres S; Krieg AM; Hartmann G
    Eur J Immunol; 2001 Oct; 31(10):3026-37. PubMed ID: 11592079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
    Bento D; Staats HF; Gonçalves T; Borges O
    Eur J Pharm Biopharm; 2015 Jun; 93():149-64. PubMed ID: 25818119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant.
    Hafner AM; Corthésy B; Merkle HP
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1386-99. PubMed ID: 23751781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
    Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
    Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
    Arsenault RJ; Kogut MH; He H
    Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new strategy based on SmRho protein loaded chitosan nanoparticles as a candidate oral vaccine against schistosomiasis.
    Oliveira CR; Rezende CM; Silva MR; Pêgo AP; Borges O; Goes AM
    PLoS Negl Trop Dis; 2012; 6(11):e1894. PubMed ID: 23209848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined TLR stimulation with Pam3Cys and Poly I: C enhances Flt3-ligand dendritic cell activation for tumor immunotherapy.
    Lim SN; Kuhn S; Hyde E; Ronchese F
    J Immunother; 2012; 35(9):670-9. PubMed ID: 23090076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG-C immunostimulatory oligodeoxyribonucleotide activation of plasmacytoid dendritic cells in rhesus macaques to augment the activation of IFN-gamma-secreting simian immunodeficiency virus-specific T cells.
    Teleshova N; Kenney J; Jones J; Marshall J; Van Nest G; Dufour J; Bohm R; Lifson JD; Gettie A; Pope M
    J Immunol; 2004 Aug; 173(3):1647-57. PubMed ID: 15265893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
    Schmitt A; Li L; Giannopoulos K; Greiner J; Reinhardt P; Wiesneth M; Schmitt M
    Transfusion; 2008 May; 48(5):861-70. PubMed ID: 18208411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential activation and maturation of two porcine DC populations following TLR ligand stimulation.
    Auray G; Facci MR; van Kessel J; Buchanan R; Babiuk LA; Gerdts V
    Mol Immunol; 2010 Jul; 47(11-12):2103-11. PubMed ID: 20462636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human innate responses and adjuvant activity of TLR ligands in vivo in mice reconstituted with a human immune system.
    Cheng L; Zhang Z; Li G; Li F; Wang L; Zhang L; Zurawski SM; Zurawski G; Levy Y; Su L
    Vaccine; 2017 Oct; 35(45):6143-6153. PubMed ID: 28958808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porcine B Cell Subset Responses to Toll-like Receptor Ligands.
    Braun RO; Python S; Summerfield A
    Front Immunol; 2017; 8():1044. PubMed ID: 28890720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human B cell responses to TLR ligands are differentially modulated by myeloid and plasmacytoid dendritic cells.
    Douagi I; Gujer C; Sundling C; Adams WC; Smed-Sörensen A; Seder RA; Karlsson Hedestam GB; Loré K
    J Immunol; 2009 Feb; 182(4):1991-2001. PubMed ID: 19201852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets.
    Ito T; Amakawa R; Kaisho T; Hemmi H; Tajima K; Uehira K; Ozaki Y; Tomizawa H; Akira S; Fukuhara S
    J Exp Med; 2002 Jun; 195(11):1507-12. PubMed ID: 12045249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.
    Hornung V; Rothenfusser S; Britsch S; Krug A; Jahrsdörfer B; Giese T; Endres S; Hartmann G
    J Immunol; 2002 May; 168(9):4531-7. PubMed ID: 11970999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.